Skip to main content

Main menu

  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us

Clinical Medicine Journal

  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

User menu

  • Log in

Search

  • Advanced search
RCP Journals
Home
  • Log in
  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us
Advanced

Clinical Medicine Journal

clinmedicine Logo
  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

What is the significance of monoclonal gammopathy of undetermined significance?

Catherine Atkin, Alex Richter and Elizabeth Sapey
Download PDF
DOI: https://doi.org/10.7861/clinmedicine.18-5-391
Clin Med October 2018
Catherine Atkin
AInstitute of Inflammation and Ageing, University of Birmingham, Birmingham, UK
Roles: clinical research fellow
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alex Richter
BInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK
Roles: senior lecturer and consultant in clinical immunology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth Sapey
CInstitute of Inflammation and Ageing, University of Birmingham, Birmingham, UK
Roles: reader and consultant in respiratory medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: e.sapey@bham.ac.uk
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Information

vol. 18 no. 5 391-396
DOI: 
https://doi.org/10.7861/clinmedicine.18-5-391
PubMed: 
30287433
Published By: 
Royal College of Physicians
Print ISSN: 
1470-2118
Online ISSN: 
1473-4893
History: 
  • Published online October 4, 2018.
Copyright & Usage: 
© Royal College of Physicians 2018. All rights reserved.

Author Information

  1. Catherine Atkin, clinical research fellowA,*,
  2. Alex Richter, senior lecturer and consultant in clinical immunologyB,* and
  3. Elizabeth Sapey, reader and consultant in respiratory medicineC,*⇑
  1. AInstitute of Inflammation and Ageing, University of Birmingham, Birmingham, UK
  2. BInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK
  3. CInstitute of Inflammation and Ageing, University of Birmingham, Birmingham, UK
  1. Address for correspondence: Dr Elizabeth Sapey, Institute of Inflammation and Ageing, Queen Elizabeth Hospital, Mindelsohn Way, Edgbaston, Birmingham B15 2GW, UK. Email: e.sapey{at}bham.ac.uk

Article usage

Article usage: October 2018 to March 2021

AbstractFullPdf
Oct 2018478495579
Nov 2018237543284
Dec 2018254312262
Jan 2019166353225
Feb 201994199228
Mar 201985162248
Apr 201963132227
May 201953182251
Jun 201945119194
Jul 20195277226
Aug 20192286208
Sep 20193950223
Oct 20192531199
Nov 201903513
Dec 201906716
Jan 202003914
Feb 202003216
Mar 202006233
Apr 202009325
May 202008257
Jun 202005417
Jul 202008129
Aug 2020010524
Sep 2020010031
Oct 2020012040
Nov 2020017747
Dec 2020024138
Jan 2021019033
Feb 2021019027
Mar 2021023140

Cited By...

  • 4 Citations
  • Google Scholar
Back to top
Previous articleNext article

Article Tools

Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
What is the significance of monoclonal gammopathy of undetermined significance?
Catherine Atkin, Alex Richter, Elizabeth Sapey
Clinical Medicine Oct 2018, 18 (5) 391-396; DOI: 10.7861/clinmedicine.18-5-391

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
What is the significance of monoclonal gammopathy of undetermined significance?
Catherine Atkin, Alex Richter, Elizabeth Sapey
Clinical Medicine Oct 2018, 18 (5) 391-396; DOI: 10.7861/clinmedicine.18-5-391
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • ABSTRACT
    • Introduction
    • Monitoring MGUS improves diagnostic delay in myeloma
    • Should we routinely screen for MGUS?
    • Conclusion
    • Author contributions
    • Conflicts of interest
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Health impact of monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B-cell lymphocytosis (MBL): findings from a UK population-based cohort
  • The challenge of change: evidence, culture and expertise
  • Google Scholar

More in this TOC Section

  • Factors affecting ­individual task prioritisation in a workplace setting
  • Barriers and facilitators to integrating primary and specialist healthcare in the United Kingdom: a narrative literature review
  • The future physician
Show more Reviews

Similar Articles

Navigate this Journal

  • Journal Home
  • Current Issue
  • Ahead of Print
  • Archive

Related Links

  • ClinMed - Home
  • FHJ - Home
clinmedicine Footer Logo
  • Home
  • Journals
  • Contact us
  • Advertise
HighWire Press, Inc.

Follow Us:

  • Follow HighWire Origins on Twitter
  • Visit HighWire Origins on Facebook

Copyright © 2021 by the Royal College of Physicians